PAPER Jiao SS, Shen LL, Zhu C, Bu XL, Liu YH, Liu CH, Yao XQ, Zhang LL, Zhou HD, Walker DG, Tan J, Götz J, Zhou XF, Wang YJ

Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.

Transl Psychiatry. 2016 Oct 4;6(10):e907. PubMed.

PAPER Horiuchi Y, Kondo MA, Okada K, Takayanagi Y, Tanaka T, Ho T, Varvaris M, Tajinda K, Hiyama H, Ni K, Colantuoni C, Schretlen D, Cascella NG, Pevsner J, Ishizuka K, Sawa A

Molecular signatures associated with cognitive deficits in schizophrenia: a study of biopsied olfactory neural epithelium.

Transl Psychiatry. 2016 Oct 11;6(10):e915. PubMed.

PAPER Paterson RW, Heywood WE, Heslegrave AJ, Magdalinou NK, Andreasson U, Sirka E, Bliss E, Slattery CF, Toombs J, Svensson J, Johansson P, Fox NC, Zetterberg H, Mills K, Schott JM

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.

Transl Psychiatry. 2016 Nov 15;6(11):e952. PubMed.

PAPER Cheng Y, Cawley NX, Yanik T, Murthy SR, Liu C, Kasikci F, Abebe D, Loh YP

A human carboxypeptidase E/NF-α1 gene mutation in an Alzheimer's disease patient leads to dementia and depression in mice.

Transl Psychiatry. 2016 Dec 6;6(12):e973. PubMed.

PAPER Höglund K, Kern S, Zettergren A, Börjesson-Hansson A, Zetterberg H, Skoog I, Blennow K

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.

Transl Psychiatry. 2017 Jan 10;7(1):e995. PubMed.

PAPER Cacciottolo M, Wang X, Driscoll I, Woodward N, Saffari A, Reyes J, Serre ML, Vizuete W, Sioutas C, Morgan TE, Gatz M, Chui HC, Shumaker SA, Resnick SM, Espeland MA, Finch CE, Chen JC

Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models.

Transl Psychiatry. 2017 Jan 31;7(1):e1022. PubMed.

PAPER Lauretti E, Li JG, Di Meco A, Praticò D

Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model.

Transl Psychiatry. 2017 Jan 31;7(1):e1020. PubMed.

PAPER Hadar A, Milanesi E, Squassina A, Niola P, Chillotti C, Pasmanik-Chor M, Yaron O, Martásek P, Rehavi M, Weissglas-Volkov D, Shomron N, Gozes I, Gurwitz D

RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.

Transl Psychiatry. 2017 Feb 14;7(2):e1035. PubMed.

PAPER Kawata M, Morikawa S, Shiosaka S, Tamura H

Ablation of neuropsin-neuregulin 1 signaling imbalances ErbB4 inhibitory networks and disrupts hippocampal gamma oscillation.

Transl Psychiatry. 2017 Mar 7;7(3):e1052. PubMed.

PAPER Masini D, Lopes-Aguiar C, Bonito-Oliva A, Papadia D, Andersson R, Fisahn A, Fisone G

The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism.

Transl Psychiatry. 2017 Apr 11;7(4):e1088. PubMed.

PAPER Gibson J, Russ TC, Adams MJ, Clarke TK, Howard DM, Hall LS, Fernandez-Pujals AM, Wigmore EM, Hayward C, Davies G, Murray AD, Smith BH, Porteous DJ, Deary IJ, McIntosh AM

Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data.

Transl Psychiatry. 2017 Apr 18;7(4):e1094. PubMed.

PAPER Hägg S, Zhan Y, Karlsson R, Gerritsen L, Ploner A, van der Lee SJ, Broer L, Deelen J, Marioni RE, Wong A, Lundquist A, Zhu G, Hansell NK, Sillanpää E, Fedko IO, Amin NA, Beekman M, de Craen AJ, Degerman S, Harris SE, Kan KJ, Martin-Ruiz CM, Montgomery GW, NeuroCHARGE Cognitive Working Group, Adolfsson AN, Reynolds CA, Samani NJ, Suchiman HE, Viljanen A, von Zglinicki T, Wright MJ, Hottenga JJ, Boomsma DI, Rantanen T, Kaprio JA, Nyholt DR, Martin NG, Nyberg L, Adolfsson R, Kuh D, Starr JM, Deary IJ, Slagboom PE, van Duijn CM, Codd V, Pedersen NL

Short telomere length is associated with impaired cognitive performance in European ancestry cohorts.

Transl Psychiatry. 2017 Apr 18;7(4):e1100. PubMed.

PAPER Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L

Depression as a modifiable factor to decrease the risk of dementia.

Transl Psychiatry. 2017 May 2;7(5):e1117. PubMed.

PAPER Rao JS, Rapoport SI, Kim HW

Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain.

Transl Psychiatry. 2017 May 9;7(5):e1127. PubMed.

PAPER Zhao ZA, Zhao Y, Ning YL, Yang N, Peng Y, Li P, Chen XY, Liu D, Wang H, Chen X, Bai W, Chen JF, Zhou YG

Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation.

Transl Psychiatry. 2017 May 9;7(5):e1123. PubMed.